RIXIMYO Brasilien - Portugiesisch - ANVISA (Agência Nacional de Vigilância Sanitária)

riximyo

sandoz do brasil indÚstria farmacÊutica ltda - rituximabe - antineoplasico

NIBISNU Brasilien - Portugiesisch - ANVISA (Agência Nacional de Vigilância Sanitária)

nibisnu

dr. reddys farmacÊutica do brasil ltda - carmustina - nitrosureias alquilantes

AKYNZEO Brasilien - Portugiesisch - ANVISA (Agência Nacional de Vigilância Sanitária)

akynzeo

united medical ltda - netupitanto, cloridrato de palonosetrona - antiemÉticos e antinauseantes

NORIPURUM Brasilien - Portugiesisch - ANVISA (Agência Nacional de Vigilância Sanitária)

noripurum

blanver farmoquimica e farmacÊutica s.a. - ferripolimaltose - antianemicos simples

NORIPURUM FÓLICO Brasilien - Portugiesisch - ANVISA (Agência Nacional de Vigilância Sanitária)

noripurum fólico

blanver farmoquimica e farmacÊutica s.a. - ferripolimaltose, Ácido fÓlico - antianemicos a base de ferro - associacoes medicamentosas

Adcetris Europäische Union - Portugiesisch - EMA (European Medicines Agency)

adcetris

takeda pharma a/s - brentuximab vedotin - lymphoma, non-hodgkin; hodgkin disease - agentes antineoplásicos - hodgkin lymphomaadcetris is indicated for adult patients with previously untreated cd30+ stage iv hodgkin lymphoma (hl) in combination with doxorubicin, vinblastine and dacarbazine (avd). adcetris is indicated for the treatment of adult patients with cd30+ hl at increased risk of relapse or progression following autologous stem cell transplant (asct). adcetris is indicated for the treatment of adult patients with relapsed or refractory cd30+ hodgkin lymphoma (hl):following asct, orfollowing at least two prior therapies when asct or multi-agent chemotherapy is not a treatment option. systemic anaplastic large cell lymphomaadcetris in combination with cyclophosphamide, doxorubicin and prednisone (chp) is indicated for adult patients with previously untreated systemic anaplastic large cell lymphoma (salcl). adcetris is indicated for the treatment of adult patients with relapsed or refractory salcl. cutaneous t cell lymphomaadcetris is indicated for the treatment of adult patients with cd30+ cutaneous t cell lymphoma (ctcl) after at least 1 prior systemic therapy.